Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Update: the citation’s publication details are refined from a generic ahead-of-print status to specific dates (online 1 Sep 2025, and Sep 1, 2025) for the article; no change to the article’s authors or title.
    Difference
    0.2%
    Check dated 2025-10-11T15:26:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 and added a prominent notice about government funding impacts and operating status; removed the old v3.1.0 tag.
    Difference
    1%
    Check dated 2025-10-04T12:32:12.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Updates to versioning (v3.1.0) accompany the removal of several drug-safety topics, indicating a content scope shift and a new release rather than addition of new substance in the removed areas.
    Difference
    0.2%
    Check dated 2025-09-27T08:08:47.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T01:48:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page has been updated to include a new research article on the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer, along with a revision update from v3.0.0 to v3.0.1.
    Difference
    1%
    Check dated 2025-09-05T20:00:08.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed drug information for Fruquintinib and the inclusion of various facility locations across multiple countries, while also removing previous location listings and some redundant terms.
    Difference
    5%
    Check dated 2025-08-29T18:58:23.000Z thumbnail image

Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.